Posted by Xcalibre > 2020-07-15 14:59 | Report Abuse

This stock will shoot up like a rocket once Vaccine is announce... won't have the chance to buy at that time...

Posted by geary > 2020-07-15 15:02 | Report Abuse

Frank Tan come on,limit up again...

Yup... bought...@1.81...!!!

Posted by Xcalibre > 2020-07-15 15:13 | Report Abuse

There are already 4 vaccines under Phase III trials (advance stage whereby the next stage would be approval). 11 Vaccines under phase II etc..

Researchers around the world are developing more than 155 vaccines against the coronavirus, and 23 vaccines are in human trials.

https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html

Posted by Xcalibre > 2020-07-15 15:20 | Report Abuse

Moderna Coronavirus Vaccine Shows Promise in Key Early Trial

Moderna Inc.’s Covid-19 vaccine produced antibodies to the coronavirus in all patients tested in an initial safety trial, federal researchers said, clearing an important milestone as the U.S. continues to grapple with a surge in new infections.The findings are likely to increase hopes that a vaccine can be brought to market quickly.

https://www.bloomberg.com/news/articles/2020-07-14/moderna-vaccine-produced-antibodies-in-all-patients-tested

Posted by CKNG8291 > 2020-07-15 15:31 | Report Abuse

it is too early for vaccine maybe ? and Malaysia is very little case, will this case volume benefit to Dpharma ? just question

Posted by Xcalibre > 2020-07-15 15:38 | Report Abuse

See the vaccine tracker... Vaccine can be out very soon....No one knows..

When vaccine out, it's NOT about number of covid cases anymore.
Everyone would want to take the vaccine to AVOID being contracted by the virus.
So DPharma's upside market would be the whole Malaysia's Population!!

Posted by bbc99 > 2020-07-15 15:44 | Report Abuse

Correct, how long the pandemic will over, the only weapon to fight virus is vaccine. Although malaysia cases seem getting lesser and lesser . when every country opens the border, who dare not to get vaccine injected.

Posted by sk9hian9 > 2020-07-15 15:47 | Report Abuse

Posted by Xcalibre > Jul 15, 2020 3:38 PM | Report Abuse

See the vaccine tracker... Vaccine can be out very soon....No one knows..

When vaccine out, it's NOT about number of covid cases anymore.
Everyone would want to take the vaccine to AVOID being contracted by the virus.
So DPharma's upside market would be the whole Malaysia's Population!!

plus unfulfilled demand from other countries

Posted by geary > 2020-07-15 16:33 | Report Abuse

geary Frank Tan come on,limit up again...

Yup... bought...@1.81...!!!

TG...@2.40...!!!

Posted by CKNG8291 > 2020-07-15 16:35 | Report Abuse

I think with the current volume, tomorrow will be spike up madly

Posted by CKNG8291 > 2020-07-15 16:36 | Report Abuse

bbc99 - you got the point - agreed with you.

Posted by nomadmy > 2020-07-15 22:08 | Report Abuse

Today, by right, the stock should shoot up continuously if everyone believes about the future of this company. But, I saw that many people taking the opportunity to let go their stock in hand. This left me a big question mark ?

Posted by Roslan Hamid > 2020-07-15 22:46 | Report Abuse

EPF keep accumulatin

Posted by Huattuazai > 2020-07-15 22:51 | Report Abuse

Sell when news out!

Posted by Roslan Hamid > 2020-07-15 23:50 | Report Abuse

https://www.investing.com/news/stock-market-news/stock-futures-gain-as-vaccine-hopes-offset-uschina-tensions-2229840

Posted by CannieST > 2020-07-16 06:44 | Report Abuse

AstraZeneca Stock Pops on Vaccine Trial Rumors
[Wednesday, July 15, 1:36 p.m.]
Contributed by Sarah Smith

AstraZeneca (NYSE:AZN) isn’t about to let Moderna (NASDAQ:MRNA) have the spotlight all to itself.

Investors have spent today celebrating results from Moderna’s Phase 1 trials for its novel coronavirus vaccine, mRNA-1273. According to the report, the vaccine triggered an immune response in all of the participants, and produced virus-killing antibodies. Additionally, there are no real safety concerns. This bodes well for the company, which was already the first to begin human trials.

But AstraZeneca is also causing a stir. As Barron’s Josh Nathan-Kazis reported, the intraday pop in AZN stock all started with an announcement from a well-respected British journalist, Robert Peston. Citing an anonymous source, the journalist shared that AstraZeneca would likely release positive initial news about its own trials. The company is working with the University of Oxford on the candidate.

If Peston’s anonymous source is correct, AstraZeneca will be releasing the data through the medical publication The Lancet. Investors like the rumors, as they have spent Wednesday sending AZN stock up almost 7%. But can the rumors be trusted?

Nathan-Kazis highlights a few reasons for caution. Peston’s report included very few details, and AstraZeneca has not confirmed whether or not his report is true. But AstraZeneca has been chugging along with its vaccine candidate and it would not be impossible for investors to receive trial results soon. Plus, such positive results would reaffirm its competitive position against Moderna and the vaccine collaboration between Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX).

As with all of the vaccine makers, an effective candidate is a true catalyst for star power.

Posted by CannieST > 2020-07-16 06:47 | Report Abuse

Stocks Open Higher Wednesday on Moderna Results
[Wednesday, July 15, 9:31 a.m.]
Contributed by Sarah Smith

Are we seeing the light at the end of the tunnel? It sure seems like it, especially as investors bid up stocks Wednesday morning. The opening optimism comes on novel coronavirus vaccine results from Moderna (NASDAQ:MRNA). As we have previously reported in this blog, many see a vaccine as the necessary puzzle piece to get the world back to normal. Moderna is looking to solve that puzzle.

On Tuesday, the company reported that in a Phase 1 trial of its vaccine candidate, mRNA-1273, all 45 participants found the vaccine to be safe. Also importantly, the vaccine triggered an immune response in all volunteers. Although some trial participants reported side effects from the higher doses in the trial, no one suffered anything deemed “serious adverse events.” Therefore, Moderna’s candidate checked the boxes for a successful Phase 1 trial.

Oh, and those participants that received two doses of the vaccine candidate had virus-killing antibodies exceeding those found in recovered Covid-19 patients. Talk about cause for celebration.

Bulls are certainly celebrating Wednesday morning, especially as they have long backed Moderna. MRNA stock was up almost 17% in pre-market trading. Remember, the vaccine maker has long been a standout in the race to develop a vaccine. It was also the first to begin human trials.

As a week of potentially somber second-quarter earnings and rising novel coronavirus cases continues to unfold, Moderna’s news is just what the bulls need. The S&P 500, Dow Jones Industrial Average and the Nasdaq Composite are all opening in the green.

Posted by abc123_2020 > 2020-07-16 07:10 | Report Abuse

Moderna Inc (MRNA) up high as 19 % in NASDAQ today..more hope for vaccine

Posted by chopstick > 2020-07-16 07:16 | Report Abuse

guess KJ can buy tongkat ali to refill,( just like a suam minister said minum air suam) will any company sell you u bulk and refill this vaccines as simple as that.after spending billion of $$ do malaysia had such a sophisticated lab and machinery.greedy businessman might tambah tongkat ali to double up the capacity. or anything might just happen in between. more reasonable to say the company will act as a distributor. moreover KJ is a former sport minister

Posted by NavinShah > 2020-07-16 07:51 | Report Abuse

At least this company is making healthy profit. In my opinion, one buy this stock.

Posted by chopstick > 2020-07-16 07:56 | Report Abuse

if no up today , semua masuk mulut sharks. just becos of one precise statement. kaya jadi lagi kaya , sudah kaya jadi tak kaya

Posted by shinnsohai > 2020-07-16 09:06 | Report Abuse

Mr Trump has said https://www.facebook.com/DonaldTrump/posts/10165090554180725
Here comes the bull!

Posted by INV3ST0R > 2020-07-16 09:11 | Report Abuse

after gloves it's now time for Dpharma to become the next darling

Posted by geary > 2020-07-16 09:14 | Report Abuse

Upswinging...｡◕‿◕｡

Posted by Frank Tan > 2020-07-16 09:26 | Report Abuse

@geary Good start today,both Ma Ma also up,cheers

Posted by stockraider > 2020-07-16 09:27 | Report Abuse

High risk this evening big sell off on gloves again loh...!!

Becareful loh...!!

Must do something to be safe mah...!!

Posted by stockraider > Jul 16, 2020 9:21 AM | Report Abuse X

Remember to learn from yesterday mistake, must buy official covid19 oem manufacturer Dpharma, hedge your bets on Glove b4 too late loh...!!

Lock some of your profit switch it to vaccine to hedge your bets mah..!!

Posted by Hush77 > 2020-07-16 09:30 | Report Abuse

dphama will be the next play after the gloves is over...
next phase will be the vaccine distributor and pack and fill or oem production of vaccine...

Posted by Hush77 > 2020-07-16 09:34 | Report Abuse

after they "fill and finish" the vaccine, they may even distribute or export to other countries..
so the potential for this could be huge...once vaccine producer has the vaccine ready..

Posted by Hush77 > 2020-07-16 09:38 | Report Abuse

like billions of population will need the vaccine globally , they can also export once they have agreement with the major drug maker...

Posted by turtleking > 2020-07-16 09:45 | Report Abuse

time to move here...

Posted by geary > 2020-07-16 09:52 | Report Abuse

Frank Tan @geary Good start today,both Ma Ma also

Both horses racing...for the 1st Price...hehehe...!!!

Posted by Frank Tan > 2020-07-16 09:53 | Report Abuse

This Mama will have fews stage of earning for us:
1.it is now
2.when china/america announce another stage of vaccine success
3.started to manufacture the vaccine
4 started to distribute the vaccine
5.when QR shows good profit.
Sounds good or dreaming?
Moreover Dphama with good FA,good dividen history,epf keep buying...
U know wat to do now ya..cheers

Posted by geary > 2020-07-16 09:56 | Report Abuse

Frank Tan This Mama will have fews stage of earning for us:
1.it is now
2.when china/america announce another stage of vaccine success
3.started to manufacture the vaccine
4 started to distribute the vaccine
5.when QR shows good profit.
Sounds good or dreaming?
Moreover Dphama with good FA,good dividen history,epf keep buying...
U know wat to do now ya..cheers
16/07/2020 9:53 AM

Yup become Yuppie...!!!

Posted by Hush77 > 2020-07-16 09:57 | Report Abuse

next year will run 10X like gloves....

Posted by Xcalibre > 2020-07-16 10:12 | Report Abuse

Yea just buy in and hold... the further rocketing of the price will come...

Posted by Hush77 > 2020-07-16 10:19 | Report Abuse

yes... according to KJ only 2 company that is selected to handle and distribute the vaccine... so next year once vaccine is ready, dphama will rise like glove counters...10x...
now price is still low i think..

Posted by Xcalibre > 2020-07-16 10:19 | Report Abuse

Some more this stock has dividend of about 3%... better than FD!

Posted by chopstick > 2020-07-16 10:45 | Report Abuse

many ppl is promoting, i 'm just wondering,

Posted by BullRUN2021 > 2020-07-16 10:58 | Report Abuse

Every counter is like that doubt>dont believe> FOMO> EUPHORIA> just a correction> music stops.

Posted by Witty > 2020-07-16 11:01 | Report Abuse

short and long term both look attractive. potential.

Posted by Xcalibre > 2020-07-16 11:17 | Report Abuse

Not all counters are like that... Only those with good fundamental, right industry, great potential & if got dividend then its a bonus...Now have to be very selective...

Posted by BullRUN2021 > 2020-07-16 11:20 | Report Abuse

yes, im super long dpharma, good for long term or theme play

Posted by chshzhd > 2020-07-16 11:21 | Report Abuse

good buy ..

Posted by chopstick > 2020-07-16 11:28 | Report Abuse

must try la then

Posted by Hush77 > 2020-07-16 11:57 | Report Abuse

the glove play is numbered as the vaccine is coming out soon...
hence the next play will be those vaccine producer or OEM of distributor.. dphama is one of them selected to do the distribution etc..
so it may move like glove early on..
dont miss this boat!!

Posted by stockraider > 2020-07-16 11:58 | Report Abuse

Just Prepare the umbrella b4 it rains Mah...!

Posted by stockraider > Jul 16, 2020 11:14 AM | Report Abuse X

Yes don put 100% on vaccine but at least put some in dpharma to diversify your risk loh...!!

Posted by dumbdumb123 > Jul 16, 2020 11:11 AM | Report Abuse

Dont put 100% faith in vaccines to fight the pandemic. It is an RNA virus, it keeps mutating slightly all the time. Antigenic drift. Like the common flu virus.Vaccines may help. but physical measures are still of paramount importance..

Posted by hengsame > Jul 16, 2020 11:55 AM | Report Abuse

When will a coronavirus vaccine be available?
The U.S. government aims to get a vaccine to the public by January with its program called Operation Warp Speed. As part of Operation Warp Speed, the Department of Health and Human Services offered as much as $483 million in support to Moderna, $1.2 billion to AstraZeneca, and $456 million to Johnson & Johnson.

Moderna says it's on target to deliver about 500 million doses per year, and possibly as many as 1 billion, by next year. Oxford researchers, referring to the AstraZeneca vaccine, said they'd have efficacy results from their phase 3 trial this fall in "the best-case scenario."

For all companies investigating vaccines, trial results will determine the final timeline. If all goes well, it's possible one or more companies may meet the government's goal. However, any headwinds could slow the process.

Posted by Hush77 > 2020-07-16 12:04 | Report Abuse

dphama existing manufacturing line will be use to fill and distribute the vaccine..
the original vaccine maker like modena may not be able to cope the production and distribution of the vaccines.. as the demand is too much.. whole world will need it..
thats when dphama can come in.... and catch some of that demand pie...

Posted by investory321 > 2020-07-16 12:05 | Report Abuse

even without this vaccine news, with EPS of 2 cents per qtr will put the counter fair value at 2.30 (check out my comment during mid june)…

now when vaccine available EPS will be much higher, no one knows what is the cost and profit margin of the vaccine yet, but assuming each dose of vaccine Dpharma earn Rm10 profit, with 10 million of Malaysia population take the vaccine and dpharma get 50% of market share, it will generate extra Rm50 m profit to the company, which translate to additional 7 cents EPS per year

Posted by CKNG8291 > 2020-07-16 14:22 | Report Abuse

i missed the glove counter, so this should be the next potential stock to buy.

Posted by Frank Tan > 2020-07-16 14:28 | Report Abuse

Another red sea shows in glove?